Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karin Damm Jørgensen is active.

Publication


Featured researches published by Karin Damm Jørgensen.


Pharmacology & Toxicology | 2000

A dose-finding study of in utero and lactational exposure to diethylstilboestrol and flutamide in 129/Sv mice.

Thuri J. S. Kledal; Ewa Rajpert-De Meyts; Niels E. Skakkebæk; Karin Damm Jørgensen

The purpose of the study was to test the experimental conditions and find the appropriate dose range for further investigations of the disruptive effects of oestrogens and antiandrogens on the development of testis. Groups of four 129/Sv mice were exposed from day 6 after mating until weaning to 1, 10 or 100 microg/kg/day of the non-steroidal oestrogen diethylstilboestrol and to 0.1, 1 or 10 mg/kg/day of the non-steroidal antiandrogen flutamide. The number of implantation sites, the litter size and reproductive parameters were examined and nipple development, anogenital distance and testicular morphology were investigated in the offspring. Dose-related post-implantation loss was seen in both diethylstilboestrol- and flutamide-treated dams and the mean litter size was smaller in the groups given the high dosages of diethylstilboestrol and flutamide. Disturbance of testicular development was seen in males exposed to diethylstilboestrol. Because of the small data material, no statistical analyses were performed. Our findings indicate that very high doses of both diethylstilboestrol and flutamide given at early stages of gestation result in a high post-implantation loss and should be avoided in further experiments using this strain which is known to have a poor reproductive performance. Exposure of the dams before mating may better reflect human exposure, but will presumably require even lower dose levels.


Archive | 1986

Biosynthetic Human Growth Hormone Identical to Authentic Material

Thorkild Christensen; Jørli W. Hansen; John Pedersen; Henrik Dalbøge; Søren Carlsen; Ejner Bech Jensen; Karin Damm Jørgensen; Bo Dinesen; Povl Nilsson; Hans Holmegaard Sørensen; Johannes Thomsen; Anne-Marie Kappelgaard

The major component of human growth hormone (hGH) is a protein with 191 amino acid residues, and a molecular weight of approximately 22,000 D (22K-hGH). A minor component which constitutes about 5% of the more abundant form has a molecular weight of approximately 20,000 D. The minor form is derived from the major by deletion of 15 amino acid residues (32–46 of the 22K-isomer). Both molecules are single stranded, and two disulfide bridges stabilizes the structure. The N-terminus as well as the C-terminus is phenylalanine (Chawla et al., 1983).


Pharmacology & Toxicology | 1988

Biosynthetic Human Growth Hormone: Subchronic Toxicity Studies in Rats and Monkeys

Karin Damm Jørgensen; Ove Svendsen; R. J. Greenough; T. Kallesen; R. Goburdhun; K. Skydsgaard; J. Finch; Bo Dinesen; Povl Nilsson


Pharmacology & Toxicology | 1988

Pharmacokinetics of Biosynthetic and Pituitary Human Growth Hormones in Rats

Karin Damm Jørgensen; J. D. Monrad; L. Brøndum; Bo Dinesen


Pharmacology & Toxicology | 1991

Effect of human growth hormone on the reproduction of female rats.

Karin Damm Jørgensen; Ove Svendsen; N. Agergaard; K. Skydsgaard


Pharmacology & Toxicology | 2009

Actions of Fenfluramine on Glucose Uptake in Vitro and in Vivo

Karin Damm Jørgensen


Archive | 1988

Human growth hormone unit dose for the treatment of intoxicated individuals

Karin Damm Jørgensen


Pharmacology & Toxicology | 2009

The Pharmacology of a New Hypoglycaemic Agent N‐[4‐(2‐(2,3‐dihydrobenzo (b) furan‐7‐carboxamido)‐ethyl)‐ benzenesulphonyl]‐N′‐cyclohexylurea (NOVO CS 476). II. Pharmacological Studies on the Mechanism of Action

Karin Damm Jørgensen


Pharmacology & Toxicology | 2009

The Pharmacology of a New Hypoglycaemic Agent N-[4-(2-(2,3-dihydrobenzo(b)furan-7-carboxamid o)-ethyl) -benzenesulphonyl]-N′-cyclohexylurea (NOVO CS 476). III. General Pharmacological Studies

Karin Damm Jørgensen


Pharmacology & Toxicology | 1989

Interaction of Human Growth Hormone and Gonadotrophins on the Function of Rat Ovaries

Karin Damm Jørgensen; Jette Nowak

Collaboration


Dive into the Karin Damm Jørgensen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ove Svendsen

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. D. Monrad

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge